PATENT CLAIM ANALYSIS

Application Number: 15992126
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2019-12
Patent Classification: ["424", "725000"]

Abstract:
A method for treating a subject suffering from a developmental retinal vascular disorder by administering to the subject a composition which has a therapeutically effective amount of a dendrobium nobile lindley (DNL).

Claim (Index 9):
The method of  claim 1 , wherein the DNL downregulates the level of PLGF and upregulates the level of norrie disease protein to treat the developmental retinal vascular disorder induced by downregulating of norrie disease protein.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 93.0
- Lexical Diversity: 1.16667
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15490863', '14953026', '13499481', '13246057', '12645991']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7466321035604077
- 35 USC 102 Novelty (BERT): 0.5346714648329258
- Combined Prediction Score: 0.7254360396876595
- Mean Citation Score: 260.90640599999995
- Max Citation Score: 363.78384
- Similarity Product: 232.06052847942348

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test